Novavax, Inc. (NVAX)
NASDAQ·Healthcare·Biotechnology
$9.51
-10.80%
Mkt Cap $1.57B
Analyst Ratings
Buy
1
Hold
0
Sell
1
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
Implied Upside
+89.4%
Consensus $18.00 vs current $9.51
NASDAQ·Healthcare·Biotechnology
$9.51
-10.80%
Mkt Cap $1.57B
Buy
1
Hold
0
Sell
1
Price Target (8 analysts)
$18.00
Range $11.00 – $25.00
+89.4%
Consensus $18.00 vs current $9.51